Citralah is a modern hybrid-indica cultivar derived from the cross-breeding of Afghani and Hawaiian genetics. As a deliberate fusion of these ancestral lines, the strain is engineered for reliability and consistent performance in both indoor and outdoor cultivation environments. Growers typically reach harvest after a flowering period of 63 days, with the plant categorized as having a moderate difficulty level and a capacity for high yields.

The dominant aromatic and flavor profile is defined by a complex sequence of terpenes, led by terpinolene, myrcene, and pinene. This primary foundation is followed by secondary and tertiary contributions from limonene, caryophyllene, ocimene, beta-pinene, humulene, and linalool. The full chemical expression concludes with trace amounts of bisabolol, guaiol, alpha-terpinene, nerolidol, and gamma-terpinene, ensuring a layered sensory experience characterized by these specific volatile organic compounds.

As a THC-dominant cultivar, Citralah is chemically formulated to induce effects described as relaxed, calm, and focused. These properties make it a candidate for addressing conditions related to pain, stress, and sleep. Beyond its immediate therapeutic application, the strain has secured a documented genetic legacy as a parent, notably appearing in the genealogy of G13 Haze Citralah.